Schultheiss / Kapp / Grötzbach | Chronic Viral and Inflammatory Cardiomyopathy | Buch | sack.de

Schultheiss / Kapp / Grötzbach Chronic Viral and Inflammatory Cardiomyopathy



2006, Band: 55, 370 Seiten, Kartoniert, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 593 g Reihe: Ernst Schering Foundation Symposium Proceedings
ISBN: 978-3-642-42143-3
Verlag: Springer


Schultheiss / Kapp / Grötzbach Chronic Viral and Inflammatory Cardiomyopathy

Following its tradition of promoting novel areas of scienti?c discourse, the Ernst Schering Research Foundation (ESRF) hosted this workshop on chronic viral and in?ammatory cardiomyopathy. In late October 2004, scientists from Canada, Germany, the Georgian Republic, Great Britain, Italy, Japan, the Netherlands, Israel, Sweden, and the United States ga- ered in Berlin to discuss their concepts, hypotheses, and latest ?ndings on myocarditis and cardiomyopathy. This expert meeting was held in cooperation with the German - search Foundation, which in the same year had supported transregional collaborative research activities entitled “In?ammatory Cardiomyo- thy – Molecular Pathogenesis and Therapy.” Organizing the workshop, our efforts strove to render tighter the network between the distinct disciplines involved in cardiomyopathy - search, building bridges between its molecular, pathogenetic, diagnostic, and therapeutic determinants. It all began as a story of a neighborhood, and we would like to express our hope that this long-term project, which will require much and - tensive cooperative work among the participants, will evolve to become a story of a good neighborhood.

Zielgruppe


Professional/practitioner

Weitere Infos & Material


Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis.-Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy.- Frontiers in Viral Diagnostics.- Is Virus Persistence a Determinant for Disease Progression?- Parvovirus B19 - The Causative Agent of Dilated Cardiomyopathy or an Harmless Passenger of the Human Myocard?- Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy.- Role of Hepatitis C Virus in Cardiomyopathies.-Recent Insights into the Role of Host Innate and Acquired Immunity Responses.- The Significance of Autoimmunity in Myocarditis.- The Roles of Immunity and Autoimmunity in Chronic Heart Failure.- Clinical Implications of Anti-Cardiac Immunity in Dilated Cardiomyopathy.- Inflammation and Cardiac Remodeling During Viral Myocarditis.- Is There a Virus Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy?- New Non-Invasive Approaches for the Diagnosis of Cardiomyopathy: MRI.-New Therapeutics Targets in Chronic Viral Cardiomyopathy.-Anti-Viral Treatment in Patients with Virus-Induced Cardiomyopathy.- Immunosuppressive Treatment of Chronic Non-Viral Myocarditis.-Immunoabsorption in Dilated Cardiomyopathy


WIR VERWENDEN COOKIES

Einige Cookies sind notwendig für den Betrieb der Seite, während andere uns helfen, Ihnen ein optimales Erlebnis unserer Webseite zu ermöglichen.